SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001410578-23-002502
Filing Date
2023-11-15
Accepted
2023-11-15 17:11:15
Documents
87
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q tmb-20230930x10q.htm   iXBRL 10-Q 2101034
2 EX-31.1 tmb-20230930xex31d1.htm EX-31.1 12650
3 EX-31.2 tmb-20230930xex31d2.htm EX-31.2 12543
4 EX-32 tmb-20230930xex32.htm EX-32 9992
  Complete submission text file 0001410578-23-002502.txt   9443529

Data Files

Seq Description Document Type Size
5 EX-101.SCH tmb-20230930.xsd EX-101.SCH 79078
6 EX-101.CAL tmb-20230930_cal.xml EX-101.CAL 60472
7 EX-101.DEF tmb-20230930_def.xml EX-101.DEF 217010
8 EX-101.LAB tmb-20230930_lab.xml EX-101.LAB 608801
9 EX-101.PRE tmb-20230930_pre.xml EX-101.PRE 425296
81 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20230930x10q_htm.xml XML 1792503
Mailing Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036 973-242-0005
Petros Pharmaceuticals, Inc. (Filer) CIK: 0001815903 (see all company filings)

IRS No.: 851410058 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39752 | Film No.: 231411499
SIC: 2834 Pharmaceutical Preparations